Bob Manning is an experienced entrepreneur and the CEO at CureMatch, biotechnology digital health company focused on personalized medicine and combination therapy in oncology by using molecular profiles to determine the best treatment options for cancer patients. Bob has 20 years of experience in technology and health care, including medical device, IT and services. He is an expert at delivering products to the market and executing on business strategy. As co-founder of TruMed Systems, he transformed the way that physician offices manage and store vaccines, preserving efficacy and reducing disease outbreaks. He holds three patents from his work there. While at CareFusion he was an innovator in hosting PHI and HIPAA governed data, creating an analytics platform that generated millions in new incremental revenue. Bob has additionally worked at SAP, IBM, Teradata and Parametric Technology. Bob holds a BS from the University of Massachusetts and an MBA from Babson College.